Humanized mouse models for preclinical evaluation of novel immune cell therapies, checkpoint inhibitors, and immune cell engagers

被引：0
|
作者：
Stecklum, Maria [1 ]
Wulf-Goldenberg, Annika [1 ]
Brzezicha, Bernadette [1 ]
Walther, Wolfgang [1 ]
Hoffmann, Jens [1 ]
机构：
[1] EPO GmbH, Berlin, Germany
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1650
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in sinonasal squamous cell carcinoma
    Park, Jong Chul
    Faquin, William C.
    Durbeck, Julia
    Faden, Daniel L.
    [J]. ORAL ONCOLOGY, 2020, 109
  • [32] Immune checkpoint inhibitors in follicular dendritic cell sarcoma
    Assi, Tarek
    Cesne, Axel Le
    [J]. IMMUNOTHERAPY, 2024, 16 (06) : 341 - 344
  • [33] Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
    Parikh, Mamta
    Bajwa, Poornima
    [J]. SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 76 - 85
  • [34] Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martin, Spencer D. D.
    Bhuiyan, Ishmam
    Soleimani, Maryam
    Wang, Gang
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [35] Editorial: Immune checkpoint inhibitors in renal cell carcinoma
    Tykodi, Scott S. S.
    Pichler, Renate
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Humanized mouse model: A model to understand mechanisms of immune non-responsiveness to immune checkpoint inhibitors in melanoma.
    Somasundaram, Rajasekharan
    Samarkina, Anastasia
    Connelly, Thomas
    Choi, Robin
    Choi, Hedy
    Muthumani, Kar
    Xu, Xiaowei
    Kaestner, Klaus
    Herlyn, Meenhard
    [J]. CANCER RESEARCH, 2020, 80 (19) : 43 - 43
  • [37] Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma
    Mason, N.
    Kim, Y.
    Shah, S.
    Adashek, J. J.
    Manley, B. J.
    Spiess, P. E.
    Chahoud, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S692 - S692
  • [38] Immune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas
    Boileve, A.
    Carlo, M.
    Barthelemy, P.
    Oudard, S.
    Borchiellini, D.
    Voss, M.
    George, S.
    Chevreau, C.
    Landman-Parker, J.
    Tabone, M-D.
    Chism, D.
    Amin, A.
    Bilen, M. A.
    Bosse, D.
    Choueiri, T. K.
    Tannir, N.
    Malouf, G.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [39] IMMUNE CHECKPOINT INHIBITORS AND THE KIDNEY; NEUTRALIZING THE T CELL HYPER IMMUNE RESPONSE
    Duque, Juan
    Barisoni, Laura
    Contreras, Gabriel
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 535 - 535
  • [40] THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NEUROBLASTOMA MOUSE MODEL: MASS VS FLOATING CELL
    Saito, Takeshi
    Fuchimoto, Yasushi
    Hirabayashi, Takeshi
    Kuroda, Tatsuo
    Hakamada, Kenichi
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69
12345